Introducing
The Emerge™ Platform
The Emerge™ Platform Includes:
A Whole Genome Sequencing and Analysis
On-Demand, Multilingual Genetic Counseling
Disease-Specific Next Steps
Diagnosing a rare disease quickly requires a thorough, personalized approach.
The Emerge platform provides the information needed to diagnose, understand family impact, and take the next steps.
Whole Genome Sequencing,
Interpretation and Reporting
We are excited to bring the services of Broad Clinical Labs (BCL) to patients. This CLIA-licensed and CAP-accredited lab has powered some of the world’s largest WGS projects, including the Human Genome Project. Unlike other tests that focus on specific genes and leave out large portions of your genetic code, our test analyzes your whole genome of roughly 20,000 genes with results returned as early as 4 weeks. The final result is a patient report that can help inform your physician to make a diagnosis.
Each patient report is provided with a customized interpretation that leverages genomic, phenotypic, and clinical data to achieve extreme sensitivity.
You can also include ACMG 78 screening at no extra cost. Variants of these 78 genes are linked to medically actionable conditions that are preventable or treatable (such as BRCA, Lynch Syndrome, and familial high cholesterol).
On-Demand, Multilingual
Genetic Counseling
Jura Health provides access to pre-and post-test genetic counseling to answer specific questions about the genetic results and the potential impact on their family. Patients can speak live with a genetic counselor or through an asynchronous 30-day chat. Most appointments can be made in less than three working days and in one of 50 languages.
Disease-Specific Next Steps
Support Guide
Jura Health believes no patient with a rare disease should take the journey alone. As a critical component of the Emerge Platform, we offer each patient a personalized collection of rare disease advocacy groups, research, clinical trials, and insurance support.